James L Tyree Chemo Centryx, Inc. (CCXI) insider trading activity

James L Tyree is Director of ChemoCentryx, Inc.. Currently has a direct ownership of 0 shares of CCXI, which is worth approximately $0. The most recent transaction as insider was on Oct 20, 2022, when has been sold 9,138 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

James L Tyree Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 20 2022	SELL Sale (or disposition) back to the issuer	-	9,138 Reduced 100.0%	0 Common Stock
Aug 04 2022	SELL Open market or private sale	$502,200 $50.22 p/Share	10,000 Reduced 52.25%	9,138 Common Stock
Jun 09 2022	SELL Open market or private sale	$100,168 $25.93 p/Share	3,863 Reduced 16.79%	19,138 Common Stock
May 20 2022	BUY Exercise of conversion of derivative security	-	7,726 Added 25.14%	23,001 Common Stock
Dec 17 2021	SELL Open market or private sale	$1,297,125 $34.59 p/Share	37,500 Reduced 71.06%	15,275 Common Stock
Dec 17 2021	BUY Exercise of conversion of derivative security	$507,000 $13.52 p/Share	37,500 Added 41.54%	52,775 Common Stock
May 21 2021	SELL Open market or private sale	$23,951 $9.76 p/Share	2,454 Reduced 13.84%	15,275 Common Stock
May 21 2021	BUY Exercise of conversion of derivative security	-	4,660 Added 20.81%	17,729 Common Stock

Also insider at

ASRT

Assertio Holdings, Inc. Healthcare

Director

GNLX

GENELUX CORP

JLT

James L Tyree

Director

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CCXI shares.

Notify only if

Value

Insider Trading

Get notified when an Chemo Centryx, Inc. insider buys or sells CCXI shares.

Notify only if

Operation

Value

Type

News

Receive news related to ChemoCentryx, Inc.

Track Activities on CCXI

Account